| Literature DB >> 35405846 |
Robert Hermes1, Alexis Lecu2, Romain Potier3, Frank Goeritz1, Jessica P Rickard4, Julia Bohner5, Rudy Wedlarski6, Jiri Hruby7, Thomas B Hildebrandt1.
Abstract
Giraffe numbers have plummeted over the last 30 years by 30-40%. Thus, their conservation status has been raised from least concern to vulnerable. Efforts to manage in situ and ex situ populations are increasing. Assisted reproduction techniques (ART) such as sperm cryopreservation could help preserve the genetic diversity of giraffe subspecies and, when used for artificial inseminations, enhance genetic exchange between isolated populations. However, to date, the post-thaw motility of recovered sperm has been low and inconsistent. In this study, epididymal sperm collected from the testes of giraffes (n = 7) was frozen in three different extenders, namely, BotuCrio, Steridyl, and test egg yolk (TEY), each supplemented with one of two different cryoprotectants (5% glycerol or a mix of 1% glycerol and 4% methylformamide) and frozen over liquid nitrogen vapor. Across all three extenders, sperm showed significantly better post-thaw results when frozen with a mix of glycerol and methylformamide compared with glycerol alone. Sperm frozen with TEY and a mix of glycerol and methylformamide achieved superior post-thaw total and progressive sperm motility of 57 ± 3% and 45 ± 3%, respectively. These results show the benefit of using alternative cryoprotectants for freezing giraffe spermatozoa and could aid in the application of ARTs for giraffe subspecies or the closely related endangered Okapi.Entities:
Keywords: assisted reproduction technologies; epididymis; freezing; giraffidae; glycerol; methylformamide
Year: 2022 PMID: 35405846 PMCID: PMC8997136 DOI: 10.3390/ani12070857
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Overview of giraffe sperm cryopreservation studies and post-thaw results.
| Reference | Giraffe ( | Type of Sperm | Freezing Method | Freezing Extender | Cryoprotectant | Post-Thaw Motility |
|---|---|---|---|---|---|---|
| Maya Soriano, 2012 | 1 | epididymal | conventional | Gent A/B | DMSO 1%/5%/10% | <5% |
| Kaneko, 2014 | 1 | Ejaculated | freeze drying | Tris-EDTA buffer | None | 0 |
| Lueders, 2015 | 1 | Ejaculated | conventional | BIOXcell/Triladyl | Glycerol 4%/6% | not reported |
| Sipek, 2019 | 1 | epididymal | conventional | Tris-fructose-citric + 20%EY | Glycerol 6% | 44 % |
| O’Brien, 2019 | 2 | epididymal | conventional | Tris-citric-glucose + 6%EY | Glycerol 5% | not reported |
| ultra-rapid | Tris-citric-glucose + 6%EY | 100 mM sucrose | not reported |
EY: egg yolk.
Giraffe epididymal sperm characteristics (n = 7) pre-freeze without cryoprotectant assessed subjectively at 37 °C. Data are pooled over n = 7 males ± SEM. Columns which differ in superscript indicate significant differences between treatments (p < 0.05).
| Freezing Extender | BotuCrio | Steridyl | TEY |
|---|---|---|---|
| Total motility (%) | 73.7 ± 4.4 a | 79.4 ± 4.1 a | 88.9 ± 2.4 b |
| Progressive motility (%) | 73.7 ± 4.4 a | 79.4 ± 4.1 a | 88.9 ± 2.4 b |
| HOS positive (%) | 91.0 ± 1.9 a | 90.1 ± 1.5 a | 94.4 ± 1.0 b |
| Acrosome intact (%) | 94.9 ± 1.3 a | 93.9 ± 1.4 a | 96.6 ± 0.6 b |
| Normal morphology (%) | 71.0 ± 1.8 a | 80.9 ± 0.8 b | 82.1 ± 2.4 b |
Figure 1Open castration in a giraffe: (a) Opened processus vaginalis and protruding testis before surgical removal. (b) Giraffe testis, epididymis, and duct deferens. (c) Dissected cauda epididymis and ductus deferens.
Giraffe epididymal sperm characteristics (n = 7) post-thaw using glycerol and a mix of glycerol and methylformamide as cryoprotectants. Gly: 5% glycerol; Gly + MF: 1% glycerol + 4% methylformamide. Data are pooled over n = 7 males ± SEM. Columns which differ in superscript indicate significant differences between treatments (p < 0.05).
| Freezing Extender | BotuCrio | Steridyl | Test Egg Yolk | |||
|---|---|---|---|---|---|---|
| Cryoprotectant | Gly | Gly + MF | Gly | Gly + MF | Gly | Gly + MF |
| Total motility (%) | 7.0 ± 1.9 a | 29.6 ± 4.1 b | 29.7 ± 5.6 b | 52.6 ± 4.2 c | 49.0 ± 6.0 c | 57.3 ± 3.0 c |
| Progressive motility (%) | 1.1 ± 0.7 a | 13.7 ± 5.6 b | 17.6 ± 6.1b | 40.7 ± 5.1 c | 34.9 ± 6.6 c | 45.0 ± 3.3 c |
| HOS positive (%) | 76.3 ± 3.8 a | 86.7 ± 1.5 b | 75.7 ± 2.9 a | 79.0 ± 2.9 a | 84.1 ± 2.1 a | 82.7 ± 2.0 a |
| Acrosome intact (%) | 86.6 ± 1.2 | 87.3 ± 1.4 | 81.9 ± 3.2 | 82.6 ± 4.7 | 82.3 ± 4.6 | 84.4 ± 3.9 |
| Normal morphology (%) | 48.6 ± 6.1 | 45.4 ± 7.9 | 38.4 ± 5.5 | 34.4 ± 5.4 | 37.9 ± 6.8 | 38.3 ± 7.0 |
Calculated cryoresistance ratio for giraffe sperm motility, progressive motility, membrane function, acrosome, and morphology. Data are pooled over n = 7 males ± SEM. Columns which differ in superscript indicate significant differences between treatments (p < 0.05).
| Freezing Extender | BotuCrio | Steridyl | Test Egg Yolk | |||
|---|---|---|---|---|---|---|
| Cryoresistance Rate | Gly | Gly + MF | Gly | Gly + MF | Gly | Gly + MF |
| Total motility | 9.2 ± 2.4 a | 40.1 ± 5.0 b | 37.4 ± 7.0 b | 67.5 ± 6.8 c | 55.5 ± 7.0 c | 64.7 ± 3.8 c |
| Progressive motility | 1.5 ± 1.0 a | 17.5 ± 6.1 b | 21.8 ± 7.6 b | 54.4 ± 7.5 c | 39.5 ± 7.8 c | 50.8 ± 3.9 c |
| HOS positive | 83.9 ± 4.0 | 95.4 ± 1.4 | 84.1 ± 3.4 | 87.7 ± 3.1 | 89.3 ± 2.9 | 87.8 ± 2.8 |
| Acrosome intact | 91.5 ± 2.5 | 92.3 ± 2.6 | 87.5 ± 4.1 | 88.4 ± 5.6 | 85.3 ± 4.9 | 87.6 ± 4.4 |
| Morphology | 68.4 ± 8.3 | 64.1. ± 10.9 | 47.7 ± 7.1 | 42.7 ± 6.9 | 45.7 ± 8.0 | 45.8 ± 8.1 |